NPWH Position Statement on HBOC Risk Assessment
Repository Posting Date2017-05-18T19:04:04Z
Lead Author Sigma AffliationNon-member
Level of EvidenceN/A
KeywordsHereditary breast ovarian cancer; HBOC; Genetic testing; breast cancer; ovarian cancer; Position statement; Breast Neoplasms; Breast Neoplasms--Familial and Genetic; Breast Neoplasms--Prevention and Control; Genetic Screening; Ovarian Neoplasms; Ovarian Neoplasms--Familial and Genetic; Ovarian Neoplasms--Risk Factors; Risk Assessment
CINAHL HeadingsBreast Neoplasms; Breast Neoplasms--Familial and Genetic; Breast Neoplasms--Prevention and Control; Genetic Screening; Ovarian Neoplasms; Ovarian Neoplasms--Familial and Genetic; Ovarian Neoplasms--Risk Factors; Risk Assessment
This item is part of a CNE course. The material is freely available in the Henderson Repository. The CNE course (and associated fee, if any) is not part of the Henderson Repository. To access the course please click on the applicable link on the CNE collection homepage: http://www.nursinglibrary.org/vhl/handle/10755/622566. Note the start and end dates for the course. If the links to the CNE collection homepage or course are invalid, the course has ended. The item record and file will remain as a permanent entry in the repository in its original collection.
The National Association of Nurse Practitioners in Women’s Health (NPWH) supports the role of women’s health nurse practitioners (WHNPs) in providing hereditary breast and ovarian cancer (HBOC) risk assessment. At a minimum, HBOC risk assessment should include the woman’s personal cancer history; her maternal and paternal first-, second-, and third-degree relative cancer histories, with descriptions of the types of primary cancers and the ages of onset; any Ashkenazi Jewish ancestry; and the results of any cancer predisposition testing in any relative.This assessment should be reviewed and updated regularly. The goal of HBOC risk assessment is to identify women who may benefit from genetic counseling, genetic testing, enhanced surveillance, or other risk management strategies.
WHNPs should be knowledgeable about indicators of an increased risk for HBOC, as put forth by the National Comprehensive Cancer Network (NCCN).Women assessed
as being at increased risk should have access to genetic counseling by clinicians with training and expertise in cancer genetics. These specialists can provide genetic
testing if indicated and desired, psychosocial support, and evidence-based management that depends on identified risk and genetic testing results—if such testing is done.
Primary care providers with appropriate training and skills, including WHNPs, may provide HBOC genetic counseling and testing.An evidence-based protocol established according to guidelines provided by nationally recognized organizations such as NCCN must be followed to ensure that all recommended components of assessment, counseling, informed consent, appropriate testing, and follow-up are provided.
Date of Publication2017-05-18
The following license files are associated with this item: